(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
This volume is the outcome of the International School of Phar macology course sponsored as a NATO Advanced Study Institute and held in Erice (Sicily) at the Ettore Majorana Centre for Scientific Culture from October 3 through 12, 1980. The course, which consisted of lectures and teaching seminars, examined issues of international importance in all phases of drug development, assessment, and regu lation. In order to recreate both the atmosphere and substance of the meeting, a variety of materials are included here: the papers pre sented by the lecturers, a selection of key items from the supple mentary materials provided by the lecturers to the participants, notes on issues raised during the discussions, and accounts of certain special sessions arranged in response to interests expressed by those attending. The course covered two broad areas represented here by parts of the book. Part I, "Drug Assessment and Regulation," is based on the nine sessions of the course that ranged in focus from recent developments in the science of clinical pharmacology and drug development to discussions of whether and how the regulation of drug development can (or should) be harmonized internationally. In Part 11, "Postmarketing Surveillance," many aspects of this important subject are presented. Arguments outlining the potential benefits of national and international postmarketing surveillance systems are qualified by consideration of the problems inherent in devising and using these systems.
Contents:
Introduction: Science and Government in Drug Development, Regulatory Assessment, And Postmarketing Surveillance.- I Drug Assessment and Regulation.- 1. Preclinical Requirements, Guidelines, and Regulations: Public Safety and Impact on Drug Development 17.- Preclinical testing of new drugs: the CPMP Guidelines as a model for international harmonization.- Preclinical guidelines for the testing of new drugs: pharmacodynamic aspects.- Preclinical guidelines: a reply.- 2. Clinical Requirements, Guidelines, and Regulations: Current Status and Future Prospects 59.- The development of clinical guidelines.- Clinical guidelines for the assessment and evaluation of drugs.- Clinical guidelines session.- 3. The Problem of Special Populations in Providing Evidence of Safety and Efficacy for Drug Registration 77.- The problem of special populations and issues of safety and efficacy for drug registration.- Special populations and evidence of safety and efficacy for drug registration.- Special populations: summary of the discussion.- 4. The Repeated Examination of Data: Is It Scientific? Is It Ethical? 95.- Sensitivity of therapeutic trials: sequential analysis: peeking at interim results: Is it scientific? Is it ethical?.- Some problems of multiplicity in long-term intervention studies.- Sequential analysis: reply to the presentations.- 5. Taking Account of Characteristics of Therapy in the Analysis of Clinical Trial 121.- Strategies for improving the efficiency of long-term intervention studies.- Characteristics of therapy in statistical analysis.- 6. The Scientific and Ethical Basis of the Evaluation of Medicines: Are Randomized Controlled Studies Inherently Unethical and Illegal? 139.- Report: The scientific and ethical basis of the clinical evaluation of medicines.- General introduction to the Ditchley Report.- 7. What Has Been Achieved By Drug Regulation and Drug Regulators? 155.- The effects of drug regulation: a systematic analysis..- Response to the presentation by Dr. M. N. G. Dukes and Dr. Inga Lunde on the effects of regulation.- 8. Harmonization of Drug Regulatory Requirements 165.- Harmonization of regulatory requirements: centralization in the Benelux countries.- A view on harmonization.- 9. Institutional Review Boards 173.- Institutional review boards: a particular view.- II Postmarketing Surveillance.- 10. Reflections on the Report of the United States' Joint Commission on Prescription Drug Use 181.- Summary of the Report of the Joint Commission on Prescription Drug Use, Inc..- Joint Commission on Prescription Drug Use.- 11. Using PMS-Derived Information 201.- Broader uses of post-marketing surveillance.- Postmarketing surveillance: a case study.- Using postmarketing surveillance information: a reply.- Broader use of post-marketing surveillance - discussion.- 12. National and International Systems for Postmarketing Surveillance 231.- National/international systems for post-marketing surveillance.- Post-marketing surveillance.- III Simulation of the Drug Approval Process and Postmarketing Surveillance.- 13. Simulation of Drug Assessment: Katastrophex and Rejuvenal 253.- New drug application submitted to the Erician Registration Committee (Clinical Section): Katastrophex.- The Katastrophex meeting: minutes and discussion.- Bad drug applications: "Katastrophex" critique.- New drug application submitted to the Erician Registration Committee (Clinical Section): Rejuvenal.- The Rejuvenal meeting: minutes and discussion.- 14. Postmarketing Surveillance Simulation 279.- Post-marketing surveillance: hypothetical problems.- Append.- Medical research: Civil liability and compensation for personal injury. A discussion paper prepared by a Ciba Foundation Study Group.- Directions and implications of drug legislation and regulation in Europe.- Proposal for a Council Recommendation concerning tests relating to the placing on the market of proprietary medicinal products. Commission of the European Communities. COM(80) 789 final (28 November 1980).- List of Contributors.
PRODUCT DETAILS
Publisher: Springer (Springer-Verlag New York Inc.)
Publication date: August, 2012
Pages: 356
Weight: 699g
Availability: Available
Subcategories: Pharmacology
From the same series
Holger Schmid-Schonbein
C. David
Athel Cornish-Bowden
Roy H. Pottier
A Cooper
W. Taylor
Gregory Gregoriadis
Robert A. Samson
A. Pecile
Nikolas Zagris
Peter A.V. Anderson
Allan D. Callow
S.S. Davis
Gregory Gregoriadis
Kalliopi A. Roubelakis-Angelakis
F. Cattabeni
Janice S. Dorman
C. Nicolini
Ruth Bellairs
Curtis C. Travis
David L. Hawksworth
Bengt Samuelsson
Thomas Elbert
Athel Cornish-Bowden
Allan D. Callow
F. Delange
Giorgio M. Innocenti
W.C. McCallum
John Alden
Douglas R.O. Morrison
B. Marin
Brian L. Strom
Gregory Gregoriadis
M.I. Mackness
Erik De Clercq
Wilfred Cote
J. Axelrod
Jacques Dumont
Antonio Borsellino
G. Gregoriadis
Claudio Nicolini
Martino Grandolfo
Antonio Pecile
F. Lamberti
Terry J. Beveridge
Michael E. Maragoudakis
Cesare Sirtori
Curtis Travis
Shimon Gatt
Hans Degn
E.C. Tjamos
Michael E. Maragoudakis
Claudio Nicolini
P. H. Smith
M. Ali
A. Quintanilha
Jose Cunha-Vaz
C Thomas Caskey
J. E. Celis
Alan Kolber
Gurdal N. Alaeddinoglu
R. Bercoff
Stephane Swillens
J. Don Read
H. F. Bradford
Francesco Ghetti
P.M. Mannucci
Suresh C. Srivastava
John S. Axford
Frederic J. Burns
Paul F. Lurquin
Giorgio M. Innocenti
Lester Packer
Filipe Cabello
William F. Dove
F. Berti
Hubert Peeters
Claudio Nicolini
Prakash Chandra
Gregory Gregoriadis
Gregory Gregoriadis
Corrado L. Galli
Erik De Clercq
Demetrios A. Spandidos
Claudio Nicolini
H. Peeters
M. L. Thakur
R. T. Walker
Corraldo Galli
Claudio Nicolini
Robert M. Burton
Hans-Jurg Marthy
R. E. Foreman
Joan H. Argyroudi-Akoyunoglou
Miral Dizdaroglu
Francisco Rodriguez-Valera
Russel J. Reiter
Giulio Milazzo
Constantine Zervos
Arne Valberg
Allan D. Callow
J.Richard Hinchliffe
R.G. Herrmann
Nahum Sonenberg
P.J. Barnes
Franco Celada
Joseph G. Cloud
Gregory Gregoriadis
Gregory Gregoriadis
Sarnoff A. Mednick
Simon D. Shorvon
Oleg Jardetzky
Vincent Torre
J. Martin-Comin
Leo M. Chalupa
Michael E. Maragoudakis
Sarnoff A. Mednick
Gregory Gregoriadis
P. Bagnoli
E.M. Fielden
David B. Allison
Russel J. Reiter
Harry Meinardi
D.J. Galton
Gregory Gregoriadis
Jacques Breton
Richard Bandler
Andrea Boicelli
Wolfram Boucsein
Nuri Akkas
Sadis Matalon
D. Karcher
F. Berti
Lucien Ledoux
Barry W. Festoff
Claudio Nicolini
Orio Ciferri
R. Perez-Bercoff
A. Breccia
F. Hillenkamp
Rodolfo Paoletti
Robert W Wissler
R. D. Freeman
L.M.G. Heilmeyer
Ralph Bradshaw
F. Delange
B. Samuelson
G. Galli
Tom Scott
Gregory Gregoriadis
Aldo Rescigno
M.R. Ahuja
Frade Fonnum
Vincent Torre
Miguel A. Merchán
T. Norman Palmer
Gregory Gregoriadis
Robert C. Brown
Upendra K. Pandit
E. Kenneth Weir
H. Hildebrand
Allan D. Callow
M. Paubert-Braquet
Michael E. Maragoudakis
Giuliano Colombetti
Corrado L. Galli
John Stein
Ruth F. Jarrett
Gregory Gregoriadis
Ned H.C. Hwang